{
  "docId": "019de072-f0cb-7745-907c-f9e6b87d2817",
  "docSlug": "e5afd111c5ca3d26ccce5d5b91b81d60",
  "documentTitle": "BioNTech | Investor Day Presentation Deck | 156 slides",
  "authorId": "biontech",
  "authorName": "BioNTech",
  "documentKindSlug": "conference-presentation",
  "documentKindLabel": "Conference presentation",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2022-06-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7777778,
  "pageNumber": 99,
  "pageCount": 120,
  "prevPage": 98,
  "nextPage": 100,
  "slideType": "comparison_table",
  "function": "compare_peers",
  "density": "dense",
  "nDataPoints": 0,
  "notes": "The slide uses a comparison table to contrast early-line vs late-line settings across three key biological dimensions.",
  "elementsJson": null,
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019de072-f0cb-7745-907c-f9e6b87d2817/99",
  "deckHref": "/decks/019de072-f0cb-7745-907c-f9e6b87d2817",
  "deckJsonHref": "/decks/019de072-f0cb-7745-907c-f9e6b87d2817.json",
  "deckAnchorHref": "/decks/019de072-f0cb-7745-907c-f9e6b87d2817#slide-99",
  "components": [
    {
      "bbox": {
        "h": 0.25,
        "w": 0.88,
        "x": 0.07,
        "y": 0.18
      },
      "kind": "image",
      "text": "Visual representations of Adjuvant, 1L metastatic, and Late-line metastatic cancer states.",
      "attrs": null,
      "subkind": "illustration",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "e90f9a5f-3f3f-487d-94c6-f6e97daab564",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.12,
        "w": 0.45,
        "x": 0.36,
        "y": 0.82
      },
      "kind": "list",
      "text": "Three trials ongoing in early lines: Advanced melanoma (Phase 2), Adjuvant colorectal cancer (Phase 2), Adjuvant pancreatic ductal adenocarcinoma (Phase 1)",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "b133c5b2-9222-4124-afd0-1e990a7a057d",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.28,
        "w": 0.9,
        "x": 0.048,
        "y": 0.46
      },
      "kind": "table",
      "text": "Comparison table of Tumor mass, Tumor resistance mechanisms, and Immune system health across Early line and Late line settings.",
      "attrs": null,
      "subkind": "data",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "ac1f3351-cde0-4d6a-9802-6011ebd29f24",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.04,
        "w": 0.76,
        "x": 0.048,
        "y": 0.105
      },
      "kind": "title",
      "text": "Neoantigen vaccines are well suited for the early-line setting",
      "attrs": null,
      "subkind": "action-title",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "c4db52bf-df42-4394-a086-407cd11afb37",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.04,
        "w": 0.51,
        "x": 0.048,
        "y": 0.056
      },
      "kind": "title",
      "text": "iNeST | Autogene cevumeran (BNT122)",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "6b640946-bb1e-4979-910e-f2508d99c3bb",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [],
  "frameworks": [
    {
      "name": "comparison_frame",
      "slug": null,
      "matchId": "95c3545d-7f94-4776-9284-5698bd09d943",
      "evidence": "The slide explicitly compares two clinical settings across three biological criteria.",
      "confidence": 0.9
    }
  ],
  "arcBeats": [
    {
      "to": 120,
      "from": 91,
      "beatId": "bf198718-eb7f-470f-aca0-0f710fbb4f37",
      "arcName": "The Sequoia Pitch",
      "arcSlug": "sequoia-pitch",
      "beatName": "Product Pipeline",
      "beatSlug": "sequoia-pitch-product",
      "evidence": "The presentation showcases BioNTech's product pipeline, including its oncology and infectious disease programs",
      "position": 3,
      "confidence": 0.8,
      "parentBeatName": "Evidence",
      "parentBeatSlug": "evidence"
    }
  ],
  "loops": [],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}